Semble, an integrated clinical system for healthcare, has raised £11.5 million in a Series B funding round.
The company, which featured on our HealthTech 50 ranking earlier this year, was formerly known as Heydoc. Christoph Lippuner and Mikael Landau founded Semble after successfully exiting their previous startup to reduce the administrative burden on medical professionals.
The round was led by Mercia Ventures, with participation from Octopus Ventures, Smedvig Ventures and Triple Point. The London-based company will use it to consolidate its position in the UK market and expand its presence in France, where it launched earlier this month.
A report from the British Medical Association estimated that doctors in England lose 13.5 million working hours a year to inadequate IT systems. Semble is on a mission to change this through its all-in-one clinical system, which enables healthcare businesses to automate tasks while providing secure patient data exchange by integrating with third-party systems, such as hospitals, laboratories and pharmacies.
Launched in 2018, Semble is now being used by over 10,000 healthcare professionals across more than 70 specialties.
“Amplifying the impact of healthcare professionals is central to our mission. For too long, they have worked with outdated systems that take them away from what matters most – the patient,” said Lippuner.
“With this latest funding, we are looking to bring Semble to professionals across the UK and France, empowering them to spend more time on patient care.
“We will continue to invest heavily in workflow automation and integrations, positioning Semble at the forefront of AI-driven solutions, and ultimately creating a more connected healthcare ecosystem.”
Alex Gwyther of Mercia Ventures added: “The healthcare market is experiencing significant growth, but the industry’s continued reliance on legacy systems poses a real threat to its future.
“Semble is pioneering an all-in-one clinical system that enables healthcare businesses to automate many aspects of their practice.
“This investment will help Semble accelerate product development and expand its presence in the UK and France, empowering healthcare organisations to deliver on their digital transformation and transform their patients’ experience.
“With the founders’ first-hand understanding of the challenges in the healthcare sector and its rapid growth to date, we are in no doubt that Semble is well poised to seize this massive market opportunity.”